These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4804469)

  • 21. [Gastro-esophageal reflux].
    Bonardi O
    Minerva Chir; 1980 Jun; 35(12):972-4. PubMed ID: 7454028
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of metoclopramide (Cerucal) on postprandial gastroesophageal reflux].
    Pflücke F
    Dtsch Z Verdau Stoffwechselkr; 1981; 41(1):13-7. PubMed ID: 7014183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH.
    Wienbeck M; Li Q
    Scand J Gastroenterol Suppl; 1989; 165():13-8; discussion 27-8. PubMed ID: 2690320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisapride--more selective than metoclopramide.
    Drug Ther Bull; 1990 Nov; 28(23):89-90. PubMed ID: 2131232
    [No Abstract]   [Full Text] [Related]  

  • 25. The response of human gastro-oesophageal junction to orally administered metoclopramide.
    Dilawari JB; Misiewicz JJ
    Postgrad Med J; 1973 Jul; 49 Suppl 4():suppl 4:70-2. PubMed ID: 4804470
    [No Abstract]   [Full Text] [Related]  

  • 26. Metoclopramide.
    Noerr B
    Neonatal Netw; 1993 Jun; 12(4):77-8. PubMed ID: 8510629
    [No Abstract]   [Full Text] [Related]  

  • 27. Gastroesophageal reflux disease: the roles of motility in pathophysiology and therapy.
    Quigley EM
    Am J Gastroenterol; 1993 Oct; 88(10):1649-51. PubMed ID: 8213704
    [No Abstract]   [Full Text] [Related]  

  • 28. [Manometric evaluation of the action of metoclopramide in gastroesophageal reflux patients].
    Larraín A; Uribe P; Wunkhaus R; Ayala M
    Rev Med Chil; 1973 Feb; 101(2):129-31. PubMed ID: 4731771
    [No Abstract]   [Full Text] [Related]  

  • 29. Transient lower oesophageal sphincter relaxation reducers--have we hit a brick wall?
    Hershcovici T; Fass R
    Aliment Pharmacol Ther; 2011 Jun; 33(11):1256-7; author reply 1257-8. PubMed ID: 21535056
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pathophysiology, clinical aspects and therapy of gastro-esophageal reflux disease].
    Fahrländer H
    Schweiz Med Wochenschr; 1981 Apr; 111(16):550-5. PubMed ID: 7233133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Functional esophageal exploration in the assessment of gastroesophageal reflux].
    Panzer JM
    Rev Med Brux; 1994; 15(1):10-3. PubMed ID: 8191166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of metoclopramide on the lower oesophageal sphincter in late pregnancy.
    Brock-Utne JG; Dow TG; Welman S; Dimopoulos GE; Moshal MG
    Anaesth Intensive Care; 1978 Feb; 6(1):26-9. PubMed ID: 665973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of clebopride on lower esophageal sphincter pressure.
    Ribeiro V; da Silva AL; Castro Lde P
    Arq Gastroenterol; 1981; 18(2):71-4. PubMed ID: 7332503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gastroesophageal reflux. Evaluation of treatment with pirenzepine by continuous ambulatory monitoring of the pH].
    García Albarrán ; Ruiz de León ; Díaz Rubio
    Rev Esp Enferm Apar Dig; 1987 Oct; 72(4 Pt 1):303-7. PubMed ID: 3685599
    [No Abstract]   [Full Text] [Related]  

  • 35. SR 48692, a specific neurotensin receptor antagonist, has no effect on oesophageal motility in humans.
    Zerbib F; Piche T; Charles F; Galmiche JP; Bruley des Varannes S
    Aliment Pharmacol Ther; 2004 Apr; 19(8):931-9. PubMed ID: 15080855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metoclopramide in gastroesophageal reflux of infancy.
    Machida HM; Forbes DA; Gall DG; Scott RB
    J Pediatr; 1988 Mar; 112(3):483-7. PubMed ID: 3346792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of antidopaminergic drugs and H2 blockers on esophageal motility and gastroesophageal sphincter].
    Braghetto I; Henríquez A; Espinoza M; Csendes A
    Rev Med Chil; 1985 May; 113(5):428-32. PubMed ID: 2869561
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reproducibility of oesophageal sphincter pressure and gastrooesophageal reflux (author's transl)].
    Pflücke F
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(1):1-6. PubMed ID: 7075522
    [No Abstract]   [Full Text] [Related]  

  • 39. Metoclopramide: a dopamine receptor antagonist.
    DiPalma JR
    Am Fam Physician; 1990 Mar; 41(3):919-24. PubMed ID: 2407079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial.
    McCallum RW; Fink SM; Winnan GR; Avella J; Callachan C
    Am J Gastroenterol; 1984 Mar; 79(3):165-72. PubMed ID: 6367434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.